Biotech Reading List (October 2017)

Why Too Many Clinical Trials Fail -- And A Simple Solution That Could Increase Returns On Pharma R&D
David Grainger (Forbes)
 
Bacteria Can Make Tumors Worse
Derek Lowe (In the Pipeline)
 
Celebrating new therapeutic modalities
Robert Plenge (PlengeGen)
 
‘Every time it’s a battle’: In excruciating pain, sickle cell patients are shunted aside
Sharon Begley (STAT News)
 
After 20 Years, A Drug That Silences Genes Succeeds
Matthew Herper (Forbes)